Management of Left CVA in a 78-Year-Old Man with 50-69% ICA Stenosis

Immediate Evaluation and Management

The patient should be urgently evaluated by a vascular team that includes a neurologist to determine the optimal management strategy 2, 3
Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel should be initiated for at least 21 days following the CVA if revascularization is not immediately performed 3, 4
DAPT may be continued for up to 90 days in some cases, depending on bleeding risk 2

For symptomatic 50-69% ICA stenosis, carotid endarterectomy (CEA) should be considered based on age, expected life expectancy, comorbidities, and surgical risk 1, 5
If CEA is indicated, it should be performed within 14 days of symptom onset for maximum benefit 3, 4
The surgical team should have a documented perioperative stroke/death rate of <6% 3, 4
Carotid artery stenting (CAS) may be considered as an alternative to CEA if the patient has high surgical risk factors 2, 5
However, CEA is generally preferred over CAS for symptomatic stenosis 1, 5

If not undergoing immediate revascularization, DAPT with aspirin and clopidogrel is recommended for at least 21 days 3, 4
Following this period, long-term single antiplatelet therapy with either aspirin or clopidogrel should be continued 6, 3
After CEA, long-term aspirin or clopidogrel is recommended 6, 3
If CAS is performed, DAPT with aspirin and clopidogrel is recommended for at least 1 month, followed by long-term single antiplatelet therapy 3, 4
Intensive medical therapy is essential regardless of whether revascularization is performed, including diabetes management if applicable 3, 4, 7

After revascularization, duplex ultrasound surveillance is recommended within the first month 3, 4
Annual follow-up to assess neurological symptoms, cardiovascular risk factors, and treatment adherence 3, 4

The benefit of CEA in 50-69% stenosis is substantially lower than in those with ≥70% stenosis 1
In the 50-69% stenosis range, CEA is associated with a higher risk of poor outcomes in the first 2 post-procedural years, but shows benefit at 5 years 1
Revascularization is not recommended for patients with <50% stenosis 3, 4
The patient's age requires careful consideration of life expectancy and surgical risk, but age alone should not exclude appropriate candidates from revascularization 5